Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
688212.SS
STRONG SELLREMOVEShanghai Aohua Photoelectricity Endoscope Co., Ltd. · Healthcare · China · $603M · Avg Vol: $8M/d
While medical devices offer structural growth, Aohua lacks the global distribution moat and scale of market leaders, and its current financial metrics are weak.
COMPANY DESCRIPTION
Shanghai Aohua Photoelectricity Endoscope Co., Ltd. designs and manufactures flexible endoscope systems, including video processors and gastrointestinal endoscopes. The company's competitive moat is built on being one of the few domestic manufacturers capable of producing high-definition flexible endoscopes, challenging long-standing Japanese monopolies. It is a leading domestic innovator in flexible endoscopy, benefiting from import substitution policies in Chinese healthcare.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 66M | 100M | 111M | 114M | 20.2% |
| EPS | 0.02 | 0.06 | 0.02 | 0.01 | -17.5% |
| Shares | 133M | 134M | 135M | 135M | +1.0% |
| Debt | 3M | 2M | 17M | 50M | 160.2% |
| Equity | 187M | 204M | 202M | 194M | 1.2% |
| Op CF | -6M | 6M | -12M | -3M | — |
| Inv CF | -68M | -4M | 5M | -8M | — |
| Fin CF | -5M | 640,996 | 8M | 23M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688212.SS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 688212.SS | Shanghai Aohua Photoelectricity Endoscope Co., Ltd.(you) | $603M | 16 | STRONG SELL |
| 688085.SS | Shanghai Sanyou Medical Co., Ltd | $755M | 17 | STRONG SELL |
| 300869.SZ | Contec Medical Systems Co.,Ltd | $681M | 21 | SELL |
| 301370.SZ | GKHT Medical Technology Co., Ltd. | $629M | 24 | SELL |
| 301602.SZ | Shantou Institute of Ultrasonic Instrument Co., Ltd. | $1.0B | 15 | STRONG SELL |
| 2160.HK | MicroPort CardioFlow Medtech Corporation | $270M | 17 | STRONG SELL |
| 688575.SS | Shenzhen YHLO Biotech Co., Ltd. | $870M | 26 | SELL |
| 688626.SS | Xiangyu Medical Co.,Ltd | $1.2B | 20 | SELL |
| 9877.HK | Jenscare Scientific Co., Ltd. | $434M | 29 | SELL |
| 688656.SS | HOB Biotech Group Corp.,Ltd | $1.0B | 6 | STRONG SELL |
Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.0%